P021 5mg (P21) research peptide
P21 (also written P021) is a small synthetic peptidergic compound based on an active region of ciliary neurotrophic factor (CNTF). Its tetrapeptide core, Ac-DGGL, is linked to an adamantylated glycine to improve stability. This vial contains 5mg.
Specification
| Quantity per vial | 5mg |
|---|---|
| Sequence | Ac-DGGL-adamantane-G |
| Molecular formula | C27H42N6O8 |
| Molecular weight | 578.7 g/mol |
| Stated purity | ≥98% |
| Form | Lyophilised solid |
| Storage | -20°C, sealed, protected from light and moisture |
Research background
P21 has been studied in rodent models of neurogenesis and synaptic plasticity, and in models used in Alzheimer’s disease research, mostly by a single research group. Findings are preclinical, and P21 is not an approved medicine.
Further reading: search PubMed for published studies on P021.
Storage and handling
On arrival, transfer the unopened vial to storage at -20°C, protected from light and moisture. Allow it to warm to room temperature before the seal is broken. Reconstitution conditions and the handling of any solution are for the receiving laboratory to set.
Related products
P21 is listed in our Neuropeptides range. Related products include Dihexa 10mg, FGL Peptide 10mg and Pinealon 20mg. For reconstitution and sample storage, see our laboratory supplies.
For laboratory research use only. Not for human or veterinary use. Not a medicine, food, supplement or cosmetic.
Reviews
There are no reviews yet.